| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2005-11-16 15:48:42 UTC |
|---|
| Update Date | 2021-09-14 15:19:52 UTC |
|---|
| HMDB ID | HMDB0001091 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 3-Hydroxyquinine |
|---|
| Description | 3-Hydroxyquinine belongs to the class of organic compounds known as cinchona alkaloids. These are alkaloids structurally characterized by the presence of the cinchonan skeleton, which consists of a quinoline linked to an azabicyclo[2.2.2]octane moiety. 3-Hydroxyquinine has been detected, but not quantified in, a few different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), and domestic pigs (Sus scrofa domestica). This could make 3-hydroxyquinine a potential biomarker for the consumption of these foods. Based on a literature review a significant number of articles have been published on 3-Hydroxyquinine. |
|---|
| Structure | [H][C@]12CCN(C[C@]1(O)C=C)[C@@]([H])(C2)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12 InChI=1S/C20H24N2O3/c1-3-20(24)12-22-9-7-13(20)10-18(22)19(23)15-6-8-21-17-5-4-14(25-2)11-16(15)17/h3-6,8,11,13,18-19,23-24H,1,7,9-10,12H2,2H3/t13-,18+,19-,20-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 3-Hydroxyquinidine | HMDB, MeSH | | 6'-Methoxycinchonan-3,9-diol | HMDB | | 3-Hydroxyquinidine, (3alpha,9S)-isomer | MeSH, HMDB | | 3-Hydroxyquinidine, (8alpha,9R)-isomer | MeSH, HMDB | | 3-Hydroxyquinine | MeSH |
|
|---|
| Chemical Formula | C20H24N2O3 |
|---|
| Average Molecular Weight | 340.4162 |
|---|
| Monoisotopic Molecular Weight | 340.178692644 |
|---|
| IUPAC Name | (3S,4R,6S)-3-ethenyl-6-[(R)-hydroxy(6-methoxyquinolin-4-yl)methyl]-1-azabicyclo[2.2.2]octan-3-ol |
|---|
| Traditional Name | 3-hydroxyquinidine |
|---|
| CAS Registry Number | 53467-23-5 |
|---|
| SMILES | [H][C@]12CCN(C[C@]1(O)C=C)[C@@]([H])(C2)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12 |
|---|
| InChI Identifier | InChI=1S/C20H24N2O3/c1-3-20(24)12-22-9-7-13(20)10-18(22)19(23)15-6-8-21-17-5-4-14(25-2)11-16(15)17/h3-6,8,11,13,18-19,23-24H,1,7,9-10,12H2,2H3/t13-,18+,19-,20-/m1/s1 |
|---|
| InChI Key | BSRUJCFCZKMFMB-ZNYHDOEXSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as cinchona alkaloids. These are alkaloids structurally characterized by the presence of the cinchonan skeleton, which consists of a quinoline linked to an azabicyclo[2.2.2]Octane moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Cinchona alkaloids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Cinchona alkaloids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Cinchonan-skeleton
- 4-quinolinemethanol
- Quinoline
- Anisole
- Quinuclidine
- Alkyl aryl ether
- Aralkylamine
- Piperidine
- Pyridine
- Benzenoid
- Heteroaromatic compound
- Tertiary alcohol
- 1,2-aminoalcohol
- Secondary alcohol
- Tertiary aliphatic amine
- Tertiary amine
- Organoheterocyclic compound
- Azacycle
- Ether
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Aromatic alcohol
- Alcohol
- Organic nitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.49 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.45 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.73 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 258.9 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 637.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 219.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 123.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 173.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 61.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 291.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 275.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 891.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 603.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 49.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 516.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 169.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 231.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 681.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 635.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 151.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 3-Hydroxyquinine,1TMS,isomer #1 | C=C[C@@]1(O[Si](C)(C)C)CN2CC[C@@H]1C[C@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C12 | 2746.2 | Semi standard non polar | 33892256 | | 3-Hydroxyquinine,1TMS,isomer #2 | C=C[C@@]1(O)CN2CC[C@@H]1C[C@H]2[C@H](O[Si](C)(C)C)C1=CC=NC2=CC=C(OC)C=C12 | 2773.5 | Semi standard non polar | 33892256 | | 3-Hydroxyquinine,2TMS,isomer #1 | C=C[C@@]1(O[Si](C)(C)C)CN2CC[C@@H]1C[C@H]2[C@H](O[Si](C)(C)C)C1=CC=NC2=CC=C(OC)C=C12 | 2775.4 | Semi standard non polar | 33892256 | | 3-Hydroxyquinine,1TBDMS,isomer #1 | C=C[C@@]1(O[Si](C)(C)C(C)(C)C)CN2CC[C@@H]1C[C@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C12 | 2999.1 | Semi standard non polar | 33892256 | | 3-Hydroxyquinine,1TBDMS,isomer #2 | C=C[C@@]1(O)CN2CC[C@@H]1C[C@H]2[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=NC2=CC=C(OC)C=C12 | 3024.9 | Semi standard non polar | 33892256 | | 3-Hydroxyquinine,2TBDMS,isomer #1 | C=C[C@@]1(O[Si](C)(C)C(C)(C)C)CN2CC[C@@H]1C[C@H]2[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=NC2=CC=C(OC)C=C12 | 3262.7 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyquinine GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-2901000000-46662034299736c6d91a | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyquinine GC-MS (2 TMS) - 70eV, Positive | splash10-03k9-4192400000-35f213d793369e0c6fa1 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyquinine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxyquinine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyquinine 10V, Positive-QTOF | splash10-00di-0009000000-757d948be08bc83ac896 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyquinine 20V, Positive-QTOF | splash10-0ab9-0409000000-0750a9802133c3ad7e0f | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyquinine 40V, Positive-QTOF | splash10-053r-0911000000-f7b63c5080fbb178b639 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyquinine 10V, Negative-QTOF | splash10-000i-0009000000-c895e6c74087aa4b7c23 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyquinine 20V, Negative-QTOF | splash10-00dr-0119000000-8ff71092af9c3960da8e | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyquinine 40V, Negative-QTOF | splash10-0uk9-0911000000-a23d26a2164f67414c08 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyquinine 10V, Negative-QTOF | splash10-000i-0009000000-6eb038badadf80b7dada | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyquinine 20V, Negative-QTOF | splash10-000b-0489000000-9bb3e6ff8d6f7f01ae22 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyquinine 40V, Negative-QTOF | splash10-08fr-0901000000-5fd6aa84f8079b3fc2d8 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyquinine 10V, Positive-QTOF | splash10-0006-0009000000-3b43e0643b1819424eeb | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyquinine 20V, Positive-QTOF | splash10-0006-0009000000-9364abb1565c929aab29 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxyquinine 40V, Positive-QTOF | splash10-00li-0961000000-7bb8ff583560fe8cdfb7 | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|
| Synthesis Reference | Carroll, F. Ivy; Abraham, Philip; Gaetano, Kevan; Mascarella, S. Wayne; Wohl, Ronald A.; Lind, Joan; Petzoldt, Karl. (3S)-3-hydroxyquinidine, the major biotransformation product of quinidine. Synthesis and conformational studies. X-Ray molecular structure of (3S)-3-hydroxyquinidine methanesuiphonate. J. Chem. Soc., Perkin Trans. 1, 1991, 12, 3017-3026 |
|---|
| General References | - Killeen AA, Bowers LD: Fetal supraventricular tachycardia treated with high-dose quinidine: toxicity associated with marked elevation of the metabolite, 3(S)-3-hydroxyquinidine. Obstet Gynecol. 1987 Sep;70(3 Pt 2):445-9. [PubMed:3627599 ]
- Pukrittayakamee S, Wanwimolruk S, Stepniewska K, Jantra A, Huyakorn S, Looareesuwan S, White NJ: Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria. Antimicrob Agents Chemother. 2003 Nov;47(11):3458-63. [PubMed:14576102 ]
- Damkier P, Brosen K: Quinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6. Clin Pharmacol Ther. 2000 Aug;68(2):199-209. [PubMed:10976551 ]
- Ridtitid W, Wongnawa M, Mahatthanatrakul W, Raungsri N, Sunbhanich M: Ketoconazole increases plasma concentrations of antimalarial mefloquine in healthy human volunteers. J Clin Pharm Ther. 2005 Jun;30(3):285-90. [PubMed:15896247 ]
- Christensen M, Andersson K, Dalen P, Mirghani RA, Muirhead GJ, Nordmark A, Tybring G, Wahlberg A, Yasar U, Bertilsson L: The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes. Clin Pharmacol Ther. 2003 Jun;73(6):517-28. [PubMed:12811361 ]
- Mirghani RA, Hellgren U, Westerberg PA, Ericsson O, Bertilsson L, Gustafsson LL: The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo. Clin Pharmacol Ther. 1999 Nov;66(5):454-60. [PubMed:10579472 ]
- Jansson A, Gustafsson LL, Mirghani RA: High-performance liquid chromatographic method for the determination of quinine and 3-hydroxyquinine in blood samples dried on filter paper. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Sep 25;795(1):151-6. [PubMed:12957180 ]
|
|---|